Company
CuraSen Therapeutics
RETHINKING BRAIN DISEASE
Also known as CuraSen Therapeutics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- CuraSen Therapeutics, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
CuraSen Therapeutics is a privately funded biopharmaceutical company pursuing development of novel treatments, targeting a unique mechanism of action, that can viably treat a broad range of psychiatric and neurodegenerative symptoms along with positive impact on underlying disease progression.
Funding snapshot
- Total raised
- $68.6MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Series A, $54.5M2018-10-14
Funding rounds
- Round, 2024
- $5.8M2024-08-26, SEC form D sold, 7 investors
- Round, 2022
- $17.6M2022-11-01, SEC form D sold, 11 investors
- Round, 2021
- $18M2021-10-21, SEC form D sold, 10 investors
- Series A
- $54.5M2018-10-14, Company stated
- Round, 2018
- $27.2M2018-09-18, SEC form D sold, 10 investors
Loading relationship preview